Positive Data Available from Phase 4 Trial for Primary Immunodeficiencies
allinonemovie / Pixabay

Positive Data Available from Phase 4 Trial for Primary Immunodeficiencies

  In a late July 2023 news release, global healthcare company Grifols shared that positive topline data was now available from a Phase 4 clinical study evaluating XEMBIFY (immune globulin…

Continue Reading Positive Data Available from Phase 4 Trial for Primary Immunodeficiencies

Editor’s Choice: IDF Sessions on CGD, IPF Progress and FDA Approval

Happy Friday Patient Worthians! You might notice that the headline has a lot of acronyms in it... ah, welcome to the rare disease world! We DO have answers for what all of that…

Continue Reading Editor’s Choice: IDF Sessions on CGD, IPF Progress and FDA Approval